Meet the Researchers

Miranda Curtiss, M.D., Ph.D.

University of Alabama at Birmingham

CXCR5/Chi3l1 axis regulates allergic disease

Brandon DeKosky, Ph.D.

University of Kansas Center for Research, Inc.

Molecular analysis of antibody responses associated with COVID-19 respiratory distress

Partha Dutta, Ph.D.

University of Pittsburgh

Stopping Endothelial Cell Death in Pulmonary Hypertension

Hyungjin Eoh, D.V.M., Ph.D

University of Southern California

Drug resistance of Mycobacterium tuberculosis is enhanced by the trehalose metabolism remodeling

Marta Maria Gaglia, Ph.D.

Trustees of Tufts College (Tufts University)

Control of innate immune responses by SARS-CoV-2

Philip Greenberg, M.D.

Fred Hutchinson Cancer Research Center

Overcoming obstacles for cellular immunotherapy against lung cancer

Christoph Grundner, Ph.D.

Seattle Children's Hospital

Developing a Unique Dual-Action Compound to Treat Drug-Resistant TB

Aaron N. Hata, M.D., Ph.D.

Massachusetts General Hospital

Exploiting potent anti-viral immunity against lung cancer through antigenic reprograming

Summer Hawkins, Ph.D.

Trustees of Boston College

How Do Tobacco and Air Pollution Policies Impact Birth Outcomes?

Jason Hong, M.D.

University of California, Los Angeles

Understanding Pulmonary Arterial Hypertension and Predicting Drugs at Single-cell Resolution

Dan Jane-wit, M.D., Ph.D.

Yale University

The Role of ZFYVE21 in COVID-19 Respiratory Complications

Nada Y. Kalaany, Ph.D.

Boston Children’s Hospital

Identifying metabolic alterations in lung cancer-associated cachexia

Carla Kim, Ph.D.

Children's Hospital Boston

Using “Organoid” Model of Lung Cancer to Test Treatment

Ji Yeon Kim, Ph.D.

University of Illinois

Targeting Sugar Molecule Could Lead to New Lung Cancer Treatment

Chi Li, Ph.D.

University of Louisville Research Foundation, Inc.

Inhibiting Lung Adenocarcinoma Growth by Inducing Apoptosis Independent of Bcl-2 Proteins

Yuru Liu, Ph.D.

University of Illinois at Chicago

Bioactive lipid mediated Endothelial niche regulation in alveolar epithelial repair

Katharina Maisel, Ph.D.

University of Maryland-College Park

Use of Immunotherapies for Treating LAM

Hyung-Geun Moon, Ph.D.

University of Illinois at Chicago

CSF1-CSF1R pathway for allergen sensitization

Sharon Morley, M.D.,Ph.D.

Washington University in St. Louis

COVID-19 infection, NLRP3 inflammasome activation and therapeutic trials to treat ARDS in a mouse model

Somashekarappa Gowda Nanjappa, Ph.D., D.V.M.

University of Illinois at Urbana-Champaign

Immunity against pulmonary fungal infections

Jac Alexander Nickoloff, Ph.D.

Colorado State University

Targeting Lethal DNA Damage to Lung Cancer Genome Alterations

Edwin Ostrin, M.D., Ph.D.

University of Texas M.D. Anderson Cancer Center

Enzyme May Play Role in Worsening Immune Function in Lung Cancer

Griffith Parks, Ph.D.

University of Central Florida

Using a Virus to Treat Lung Cancer

Irina Petrache, M.D.

National Jewish Health

Novel risk factors for severe COVID-19 lung disease

Dmitri Petrov, Ph.D.

The Board of Trustees of the Leland Stanford Junior University (Stanford)

Barcoding Genetic Changes May Give Insight Into Lung Cancer

Valerie Press, M.D., M.P.H.

University of Chicago

Reducing COPD Hospital Readmissions

Joseph Edward Qualls, Ph.D.

Children's Hospital Medical Center

Lactate metabolism and host defense against Mycobacterium tuberculosis

Amali Samarasinghe, Ph.D.

The University of Tennessee Health Science Center

Influenza Virus Promotes Eosinophil Appetite for Bacteria

John Schoggins, Ph.D.

UT Southwestern Medical Center

New Avenue for Keeping Influenza in Check

Andreas Schwingshackl, M.D, Ph.D.

University of California, Los Angeles

TREK-1 potassium channels protect from ventilator-induced lung injury